(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the Euronext session.

The three biggest winners today are OCEANTEAM, IMCD, and FLOW TRADERS.

Financial Asset	Price	Change	Updated (EST)
OCEANTEAM (OTS.OL)	0.96	18.23%	2024-08-02 12:42:02
IMCD (IMCD.AS)	140.85	7.11%	2024-08-02 12:02:44
FLOW TRADERS (FLOW.AS)	15.97	5.48%	2024-08-02 12:02:17
PCI BIOTECH HOLD (PCIB.OL)	1.80	5.14%	2024-08-02 12:42:25
BORGESTAD (BOR.OL)	15.30	4.42%	2024-08-02 12:25:08
CELYAD ONCOLOGY (CYAD.BR)	0.26	4.14%	2024-08-02 12:06:04
CONTEXTVISION (CONTX.OL)	6.20	3.33%	2024-08-02 12:25:28
DGB GROUP N.V. (DGB.AS)	0.63	3.29%	2024-08-02 12:01:41
EASE2PAY NV (EAS2P.AS)	0.57	2.89%	2024-08-02 12:01:49
AB INBEV (ABI.BR)	57.86	2.7%	2024-08-02 12:04:50

The three biggest losers today are SEQUANA MEDICAL, ASM INTERNATIONAL, and BRUNEL INTERNAT.

Financial Asset	Price	Change	Updated (EST)
SEQUANA MEDICAL (SEQUA.BR)	1.01	-12.55%	2024-08-02 12:21:20
ASM INTERNATIONAL (ASM.AS)	549.80	-11.89%	2024-08-02 12:00:34
BRUNEL INTERNAT (BRNL.AS)	9.18	-11.58%	2024-08-02 12:01:05
EBUSCO HOLDING (EBUS.AS)	0.87	-11.04%	2024-08-02 12:01:51
BE SEMICONDUCTOR (BESI.AS)	102.70	-10.81%	2024-08-02 12:00:51
CRAYON GROUP HOLD (CRAYN.OL)	117.10	-9.99%	2024-08-02 12:25:30
WALLENIUS WILHELMS (WAWI.OL)	91.65	-9.97%	2024-08-02 12:44:40
ASML HOLDING (ASML.AS)	756.90	-8.8%	2024-08-02 12:00:36
NORDIC SEMICONDUC (NOD.OL)	129.05	-8.57%	2024-08-02 12:41:45
ELLIPTIC LABORATOR (ELABS.OL)	11.66	-8.33%	2024-08-02 12:25:47

Winners today

1. OCEANTEAM (OTS.OL)

18.23% Price Change

Oceanteam ASA does not have significant operations. Previously, it engaged in a subsea and offshore business. The company was formerly known as Oceanteam Shipping ASA and changed its name to Oceanteam ASA in December 2015. Oceanteam ASA was incorporated in 2005 and is headquartered in Baerum, Norway.

Oslo Børs Benchmark Index_GI ended the session with OCEANTEAM rising 18.23% to €0.96 on Friday, after four successive sessions in a row of losses. Oslo Børs Benchmark Index_GI dropped 2.94% to €1,408.88, following the last session’s downward trend on what was an all-around negative trend exchanging session today.

Earnings Per Share

As for profitability, OCEANTEAM has a trailing twelve months EPS of kr-0.24.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -21.79%.

More news about OCEANTEAM.

2. IMCD (IMCD.AS)

7.11% Price Change

IMCD N.V. distributes, markets, and sells specialty chemicals and ingredients in the Netherlands, rest of Europe, the Middle East, Africa, North America, South America, and the Asia-Pacific. The company provides adhesives, core materials, filler reinforcements, flame retardants, masterbatch, modifiers, operating materials, pigments, plasticizers, processing aids, PUR raw materials, rubber elastomers, solvents, stabilizers, thermoplastic elastomers, thermoplastics, thermoplastics, and other additives. It offers actives, UV sunscreens, rheology modifiers, thickeners, surfactants, emulsifiers, emollients, film formers, humectants, waxes, conditioners, hair styling polymers, solvent, solubilizers, pigments, pearls, powders and colorants, opacifiers, pearlizers, preservatives, antioxidants, fragrances, and essential oils. In addition, the company provides functional fillers, pigments, resins, and specialty solvents; taste, texture, nutrition, and function; and abrasives, acids, alkalines, anti-soil redeposition and foam control systems, bio-actives, biocides, bittering and bleaching agents, builders, capsules, chelating agents, concentrates/ready-to-use, corrosion and dye transfer inhibitors, disintegrants, dispersants, emulsifiers, enzymes, fluorinated polymers, oleo chemicals, optical brighteners, perfumes, dyes, phosphates, plasticisers, proteins, rheology modifiers and thickeners, silicones, solvents/diluents, TAED, UV-filters, and waxes. Further, it offers base oils; lubricants addictive; lubricants finished fluids; fuel additives; solvents, degreasers, and fuel compounds; and upstream, midstream, and downstream oil, gas, and energy. IMCD N.V. was founded in 1995 and is headquartered in Rotterdam, the Netherlands.

AEX-Index ended the session with IMCD rising 7.11% to €140.85 on Friday while AEX-Index slid 3.11% to €878.91.

Earnings Per Share

As for profitability, IMCD has a trailing twelve months EPS of €5.13.

PE Ratio

IMCD has a trailing twelve months price to earnings ratio of 27.46. Meaning, the purchaser of the share is investing €27.46 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 17.19%.

More news about IMCD.

3. FLOW TRADERS (FLOW.AS)

5.48% Price Change

Flow Traders Ltd. operates as a financial technology-enabled multi-asset class liquidity provider in Europe, the Americas, and Asia. The company provides liquidity support that allows investors to continue to buy or sell exchange traded products or other financial instruments. It offers liquidity through financial products. Flow Traders Ltd. was founded in 2004 and is headquartered in Amsterdam, the Netherlands.

AEX-Index ended the session with FLOW TRADERS jumping 5.48% to €15.97 on Friday, following the last session’s downward trend. AEX-Index dropped 3.11% to €878.91, following the last session’s downward trend on what was a very down trend trading session today.

Earnings Per Share

As for profitability, FLOW TRADERS has a trailing twelve months EPS of €1.62.

PE Ratio

FLOW TRADERS has a trailing twelve months price to earnings ratio of 9.86. Meaning, the purchaser of the share is investing €9.86 for every euro of annual earnings.

Volume

Today’s last reported volume for FLOW TRADERS is 351462 which is 90.58% above its average volume of 184409.

Yearly Top and Bottom Value

FLOW TRADERS’s stock is valued at €15.97 at 22:40 EST, way below its 52-week high of €20.96 and higher than its 52-week low of €15.11.

More news about FLOW TRADERS.

4. PCI BIOTECH HOLD (PCIB.OL)

5.14% Price Change

PCI Biotech Holding ASA, a biopharmaceutical company, focuses on the development and commercialization of novel therapies for the treatment of cancer through its photochemical internalization (PCI) technology platform. The company's technology platform consists of a proprietary small molecule photosensitiser (fimaporfin) and a light source; and develops photochemical internalisation (PCI), inducing light-triggered intracellular release for various therapeutic modalities, as well as photochemical lysis (PCL) comprising light-triggered cell lysis, which enhances yield and purity in viral vector manufacturing. It also explores for intratumoural immunotherapy therapeutics that identifies novel treatment combinations to overcome resistance to immune-checkpoint inhibitors and safety-issues associated with treatments; and develops nucleic acid therapeutics to improve the treatment of dermatological diseases. In addition, the company develops fimaVACC for immunotherapy indications, which is in pre-clinical study; fimaNAc, a nucleic acid therapeutics delivery technology, which is in pre-clinical study for bioprocessing and dermatology indications; and technology for viral vector manufacturing and pre-clinical research for intratumoural immunotherapy. PCI Biotech Holding ASA was incorporated in 2007 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with PCI BIOTECH HOLD rising 5.14% to €1.80 on Friday while Oslo Børs Benchmark Index_GI dropped 2.94% to €1,408.88.

Earnings Per Share

As for profitability, PCI BIOTECH HOLD has a trailing twelve months EPS of kr-0.54.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -42.13%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 8.4%, now sitting on 2.99M for the twelve trailing months.

Yearly Top and Bottom Value

PCI BIOTECH HOLD’s stock is valued at kr1.80 at 22:40 EST, way below its 52-week high of kr3.50 and way higher than its 52-week low of kr1.20.

Volume

Today’s last reported volume for PCI BIOTECH HOLD is 12034 which is 97.4% below its average volume of 464127.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, PCI BIOTECH HOLD’s stock is considered to be overbought (>=80).

More news about PCI BIOTECH HOLD.

5. BORGESTAD (BOR.OL)

4.42% Price Change

Borgestad ASA develops, manufactures, distributes, delivers, and installs refractory products in Norway. The company also develops and manages real estate properties. It operates Agora Bytom, a shopping center and a rental area, as well as a parking garage with parking spaces in Poland. Borgestad ASA was founded in 1904 and is headquartered in Skien, Norway.

Oslo Børs Benchmark Index_GI ended the session with BORGESTAD jumping 4.42% to €15.30 on Friday while Oslo Børs Benchmark Index_GI fell 2.94% to €1,408.88.

Earnings Per Share

As for profitability, BORGESTAD has a trailing twelve months EPS of kr-0.96.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -15.11%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

BORGESTAD’s EBITDA is 122.4.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter and the next is 400% and 100%, respectively.

Yearly Top and Bottom Value

BORGESTAD’s stock is valued at kr15.30 at 22:40 EST, way higher than its 52-week high of kr2.02.

Revenue Growth

Year-on-year quarterly revenue growth grew by 31.8%, now sitting on 1.02B for the twelve trailing months.

More news about BORGESTAD.

6. CELYAD ONCOLOGY (CYAD.BR)

4.14% Price Change

Celyad Oncology SA, a biopharmaceutical company, focuses on the research and development of chimeric antigen receptor T (CAR-T) cell therapies for the treatment of cancer. The company is developing shRNA non-gene-edited technology, which allows for the development of allogenic CAR T-cells through the modulation of genes encoding the TCR without the need for gene editing; multi-specific CAR T-cell platform that focuses on the NKG2D receptor; NKG2D-based CAR T-cell therapies; and B7-H6 targeting CAT T-cell therapies. It has licensing agreement with Novartis International AG regarding the United States patents related to allogeneic CAR-T cells; and research and development collaboration, and license agreements with Horizon Discovery/PerkinElmer for the use of its shRNA reagents to reduce expression of one or more defined targets. The company was formerly known as Celyad SA and changed its name to Celyad Oncology SA in June 2020. Celyad Oncology SA was founded in 2004 and is headquartered in Mont-Saint-Guibert, Belgium.

BEL 20 ended the session with CELYAD ONCOLOGY rising 4.14% to €0.26 on Friday while BEL 20 slid 2.19% to €4,015.08.

Earnings Per Share

As for profitability, CELYAD ONCOLOGY has a trailing twelve months EPS of €-1.36.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, CELYAD ONCOLOGY’s stock is considered to be oversold (<=20).

Volatility

CELYAD ONCOLOGY’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.30%, a negative 0.65%, and a positive 2.78%.

CELYAD ONCOLOGY’s highest amplitude of average volatility was 0.50% (last week), 2.62% (last month), and 2.78% (last quarter).

More news about CELYAD ONCOLOGY.

7. CONTEXTVISION (CONTX.OL)

3.33% Price Change

ContextVision AB (publ), a medical technology software company, provides image analysis and imaging for medical systems in Asia, Europe, and America. The company offers image enhancement software for 2D/3D/4D ultrasound, radiography, magnetic resonance imaging (MRI), and veterinary uses. Its products include Rivent that offers image enhancement and visualization solutions for ultrasound systems for women's health, general imaging, cardiovascular, and point of care applications; Rivent Mobile, a 2D image enhancement product for handheld units; and Rivent 3D, an image enhancement solution for 3D ultrasound. The company also provides Altumira/Altumira Plus, an artificial intelligence-powered image enhancement product for digital radiography; and Orthopedic Package for orthopedic imaging. In addition, it offers GOPView MRI2Plus, an image enhancement solution for MRI. ContextVision AB (publ) was founded in 1983 and is headquartered in Stockholm, Sweden.

Oslo Børs Benchmark Index_GI ended the session with CONTEXTVISION jumping 3.33% to €6.20 on Friday while Oslo Børs Benchmark Index_GI slid 2.94% to €1,408.88.

Earnings Per Share

As for profitability, CONTEXTVISION has a trailing twelve months EPS of kr0.43.

PE Ratio

CONTEXTVISION has a trailing twelve months price to earnings ratio of 14.42. Meaning, the purchaser of the share is investing kr14.42 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 61.1%.

More news about CONTEXTVISION.

8. DGB GROUP N.V. (DGB.AS)

3.29% Price Change

DGB Group N.V. invests in, develops, and manages carbon credits and biodiversity projects for businesses and governments in the Netherlands and internationally. The company offers nature-based solutions comprising removing or avoiding carbon emissions, tackling social, and environmental challenges; manages projects that focuses on ecosystem restoration, habitat conservation, and biodiversity enrichment; and undertakes plastic projects, which consists of removing and recycling plastic, waste reduction, and environmental conservation works, as well as carbon offsetting projects for reducing carbon footprint of companies. It also provides ESG reporting and tree integration services. The company was formerly known as Verenigde Nederlandse Compagnie N.V. and changed its name to DGB Group N.V. in January 2018. DGB Group N.V. was founded in 1957 and is based in Haarlemmermeer, the Netherlands.

AEX-Index ended the session with DGB GROUP N.V. rising 3.29% to €0.63 on Friday while AEX-Index fell 3.11% to €878.91.

Earnings Per Share

As for profitability, DGB GROUP N.V. has a trailing twelve months EPS of €-0.2.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -8.73%.

Volatility

DGB GROUP N.V.’s last week, last month’s, and last quarter’s current intraday variation average was a positive 1.82%, a negative 1.42%, and a positive 4.44%.

DGB GROUP N.V.’s highest amplitude of average volatility was 1.82% (last week), 2.97% (last month), and 4.44% (last quarter).

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, DGB GROUP N.V.’s stock is considered to be oversold (<=20).

Volume

Today’s last reported volume for DGB GROUP N.V. is 6660 which is 75.49% below its average volume of 27175.

Yearly Top and Bottom Value

DGB GROUP N.V.’s stock is valued at €0.63 at 22:40 EST, way under its 52-week high of €1.03 and way above its 52-week low of €0.38.

More news about DGB GROUP N.V..

9. EASE2PAY NV (EAS2P.AS)

2.89% Price Change

Ease2pay N.V. provides online payment services and platforms in the Netherlands. The company operates payment transaction platform, which offers users services to order and pay in one action; and parking solutions. It also operates a platform that connects travelers with providers of parking and charging facilities on the road and water. The company was formerly known as DOCDATA N.V. and changed its name to Ease2pay N.V. in February 2018. Ease2pay N.V. is based in Rotterdam, the Netherlands.

AEX-Index ended the session with EASE2PAY NV jumping 2.89% to €0.57 on Friday, after three successive sessions in a row of losses. AEX-Index dropped 3.11% to €878.91, following the last session’s downward trend on what was a very down trend exchanging session today.

Earnings Per Share

As for profitability, EASE2PAY NV has a trailing twelve months EPS of €-0.06.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -18.14%.

Yearly Top and Bottom Value

EASE2PAY NV’s stock is valued at €0.57 at 22:40 EST, way below its 52-week high of €0.85 and way above its 52-week low of €0.47.

More news about EASE2PAY NV.

10. AB INBEV (ABI.BR)

2.7% Price Change

Anheuser-Busch InBev SA/NV produces, distributes, exports, markets, and sells beer and beverages. It offers a portfolio of approximately 500 beer brands, which primarily include Budweiser, Corona, and Stella Artois; Beck's, Hoegaarden, Leffe, and Michelob Ultra; and Aguila, Antarctica, Bud Light, Brahma, Cass, Castle, Castle Lite, Cristal, Harbin, Jupiler, Modelo Especial, Quilmes, Victoria, Sedrin, and Skol brands. The company operates in North America, Middle America, South America, Europe, the Middle East, Africa, and the Asia Pacific. The company was founded in 1366 and is headquartered in Leuven, Belgium.

BEL 20 ended the session with AB INBEV jumping 2.7% to €57.86 on Friday while BEL 20 slid 2.19% to €4,015.08.

Earnings Per Share

As for profitability, AB INBEV has a trailing twelve months EPS of €2.68.

PE Ratio

AB INBEV has a trailing twelve months price to earnings ratio of 21.59. Meaning, the purchaser of the share is investing €21.59 for every euro of annual earnings.

Yearly Top and Bottom Value

AB INBEV’s stock is valued at €57.86 at 22:40 EST, below its 52-week high of €62.16 and way higher than its 52-week low of €49.17.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, AB INBEV’s stock is considered to be oversold (<=20).

More news about AB INBEV.

Losers Today

1. SEQUANA MEDICAL (SEQUA.BR)

-12.55% Price Change

Sequana Medical NV develops and commercializes treatments for patients with diuretic-resistant fluid overload in liver disease, cancer, and heart failure in Belgium, Germany, France, Switzerland, and internationally. The company products pipeline comprises alfapump system, an implantable pump system for the treatment of refractory liver ascites and malignant ascites; and Direct Sodium Removal (DSR) for the treatment of fluid overload spread across the body and heart failure. Sequana Medical NV was founded in 2006 and is headquartered in Ghent, Belgium.

BEL 20 ended the session with SEQUANA MEDICAL dropping 12.55% to €1.01 on Friday, following the last session’s downward trend. BEL 20 dropped 2.19% to €4,015.08, after two sequential sessions in a row of losses, on what was an all-around bearish trend exchanging session today.

Earnings Per Share

As for profitability, SEQUANA MEDICAL has a trailing twelve months EPS of €-1.22.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, SEQUANA MEDICAL’s stock is considered to be oversold (<=20).

Revenue Growth

Year-on-year quarterly revenue growth declined by 28.4%, now sitting on 712.17k for the twelve trailing months.

More news about SEQUANA MEDICAL.

2. ASM INTERNATIONAL (ASM.AS)

-11.89% Price Change

ASM International NV, together with its subsidiaries, engages in the research, development, manufacture, marketing, and servicing of equipment and materials used to produce semiconductor devices in Europe, the United States, and Asia. The company's products include wafer processing deposition systems for atomic layer deposition (ALD), epitaxy, silicon carbide, plasma enhanced chemical vapor deposition (PECVD), and vertical furnace systems, including low pressure chemical vapor deposition (LPCVD), diffusion, and oxidation products, as well as provides spare parts and support services. It also manufactures and sells equipment, which is used in wafer processing, encompassing the fabrication steps in which silicon wafers are layered with semiconductor devices. The company offers its products to semiconductor manufacturers. The company was formerly known as Advanced Semiconductor Materials International NV. ASM International NV was incorporated in 1968 and is headquartered in Almere, the Netherlands.

AEX-Index ended the session with ASM INTERNATIONAL sliding 11.89% to €549.80 on Friday, following the last session’s downward trend. AEX-Index slid 3.11% to €878.91, following the last session’s downward trend on what was a very negative trend trading session today.

Earnings Per Share

As for profitability, ASM INTERNATIONAL has a trailing twelve months EPS of €11.17.

PE Ratio

ASM INTERNATIONAL has a trailing twelve months price to earnings ratio of 49.22. Meaning, the purchaser of the share is investing €49.22 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 17.12%.

Volume

Today’s last reported volume for ASM INTERNATIONAL is 158422 which is 32.27% above its average volume of 119763.

Yearly Top and Bottom Value

ASM INTERNATIONAL’s stock is valued at €549.80 at 22:40 EST, way under its 52-week high of €748.00 and way higher than its 52-week low of €354.30.

Moving Average

ASM INTERNATIONAL’s worth is way under its 50-day moving average of €684.96 and below its 200-day moving average of €557.15.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter and the next is 25.3% and 91.6%, respectively.

More news about ASM INTERNATIONAL.

3. BRUNEL INTERNAT (BRNL.AS)

-11.58% Price Change

Brunel International N.V. provides secondment, project management, recruitment, and consultancy services in the Netherlands, Australasia, the Middle East, India, rest of Asia, the Americas, DACH region, and internationally. The company offers project and consulting services, such as project performance management, project risk assurance, third party vendor inspection, commissioning and startup, operational readiness and assurance, and project management offices. It also provides workforce services, including contract and permanent hire, recruitment process outsourcing, executive search, staff secondment, training courses, employee and contractor care, and market intelligence and benchmarking services; and global mobility services, such as mobility and relocation, employer of record, business/country startup support, immigration, destination assistance, medical and emergency repatriation, risk and security management, and mobilization/demobilization services, as well as travel, logistics, and accommodation services. The company serves life sciences, renewable energy, conventional energy, infrastructure, future mobility, and mining industries. Brunel International N.V. was incorporated in 1975 and is headquartered in Amsterdam, the Netherlands.

AEX-Index ended the session with BRUNEL INTERNAT falling 11.58% to €9.18 on Friday while AEX-Index slid 3.11% to €878.91.

Earnings Per Share

As for profitability, BRUNEL INTERNAT has a trailing twelve months EPS of €0.58.

PE Ratio

BRUNEL INTERNAT has a trailing twelve months price to earnings ratio of 15.83. Meaning, the purchaser of the share is investing €15.83 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.2%.

Dividend Yield

As claimed by Morningstar, Inc., the next dividend payment is on May 20, 2024, the estimated forward annual dividend rate is 0.55 and the estimated forward annual dividend yield is 5.32%.

Volatility

BRUNEL INTERNAT’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.10%, a negative 0.07%, and a positive 1.16%.

BRUNEL INTERNAT’s highest amplitude of average volatility was 0.97% (last week), 0.99% (last month), and 1.16% (last quarter).

More news about BRUNEL INTERNAT.

4. EBUSCO HOLDING (EBUS.AS)

-11.04% Price Change

Ebusco Holding N.V., together with its subsidiaries, engages in the development, manufacture, and distribution of zero emission buses and charging systems. It also provides ancillary products and services to electric vehicle ecosystem; and manufactures and supplies energy storage systems and mobile energy containers, as well as repair and maintenance services. The company operates in the Netherlands, Belgium, France, Germany, Norway, Switzerland, and Denmark. Ebusco Holding N.V. was founded in 2010 and is headquartered in Deurne, the Netherlands.

AEX-Index ended the session with EBUSCO HOLDING sliding 11.04% to €0.87 on Friday while AEX-Index fell 3.11% to €878.91.

Earnings Per Share

As for profitability, EBUSCO HOLDING has a trailing twelve months EPS of €-2.4.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -53.19%.

Yearly Top and Bottom Value

EBUSCO HOLDING’s stock is valued at €0.87 at 22:40 EST, way below its 52-week low of €1.23.

Volatility

EBUSCO HOLDING’s last week, last month’s, and last quarter’s current intraday variation average was a negative 9.90%, a negative 2.33%, and a positive 3.89%.

EBUSCO HOLDING’s highest amplitude of average volatility was 16.23% (last week), 5.45% (last month), and 3.89% (last quarter).

More news about EBUSCO HOLDING.

5. BE SEMICONDUCTOR (BESI.AS)

-10.81% Price Change

BE Semiconductor Industries N.V. engages in the development, manufacture, marketing, sale, and service of semiconductor assembly equipment for the semiconductor and electronics industries in China, the United States, Malaysia, Ireland, Korea, Taiwan, Thailand, Other Asia Pacific and Europe, and internationally. It operates through three segments: Die Attach, Packaging, and Plating. The company's principal products include die attach equipment, such as single chip, multi-chip, multi module, flip chip, thermal compression bonding, fan out wafer level packaging, hybrid and embedded bridge die bonding, and die sorting systems; and packaging equipment, including conventional, ultra-thin, and wafer level molding, as well as trim and form, and singulation systems. It also provides plating equipment, such as tin, copper, and precious metal and solar plating systems, as well as related process chemicals; and tooling, conversion kits, spare parts, and other services. The company's principal brand names include Datacon, Esec, Fico, and Meco. It offers its products primarily to multinational chip manufacturers, assembly subcontractors, and electronics and industrial companies. BE Semiconductor Industries N.V. was incorporated in 1995 and is headquartered in Duiven, the Netherlands.

AEX-Index ended the session with BE SEMICONDUCTOR sliding 10.81% to €102.70 on Friday while AEX-Index slid 3.11% to €878.91.

Earnings Per Share

As for profitability, BE SEMICONDUCTOR has a trailing twelve months EPS of €2.11.

PE Ratio

BE SEMICONDUCTOR has a trailing twelve months price to earnings ratio of 48.67. Meaning, the purchaser of the share is investing €48.67 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 40.81%.

Growth Estimates Quarters

The company’s growth estimates for the current quarter is a negative 22.7% and positive 71.1% for the next.

Revenue Growth

Year-on-year quarterly revenue growth declined by 7%, now sitting on 580.44M for the twelve trailing months.

Volatility

BE SEMICONDUCTOR’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.66%, a negative 1.48%, and a positive 2.20%.

BE SEMICONDUCTOR’s highest amplitude of average volatility was 2.62% (last week), 3.23% (last month), and 2.20% (last quarter).

More news about BE SEMICONDUCTOR.

6. CRAYON GROUP HOLD (CRAYN.OL)

-9.99% Price Change

Crayon Group Holding ASA, together with its subsidiaries, operates as an IT consultancy company. It operates through Software & Cloud Direct, Software & Cloud Channel, Software & Cloud Economics, and Consulting segments. The company provides assess and migrate services, including cloud migration assessment, maturity assessment, cloud infrastructure advisory and migration, cloud POC, cloud tenant migration, cloud connectivity, modern workplace migration, cloud security assessment, professional cybersecurity, and cloud identity; govern and optimize services comprising IT governance, license optimization, software and cloud economics, and SAM tool; operate and support services, such as modern workplace adoption, compliance recording, software and cloud advisory service desk, cloud managed services, AWS managed, and crayon managed security posture services; and data platform and AI solutions services, comprising AI solution, language technologies, data platform, visual quality inspection, and machine learning operation services. It also offers software and IT asset management services; and consulting services related to infrastructure consulting, cloud migration and deployment, bespoke software deployment and follow-up of applications. The company has operations in the Nordics, Europe, the Asia-Pacific, the Middle East and Africa, and the United States. Crayon Group Holding ASA was founded in 2002 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with CRAYON GROUP HOLD falling 9.99% to €117.10 on Friday while Oslo Børs Benchmark Index_GI slid 2.94% to €1,408.88.

Earnings Per Share

As for profitability, CRAYON GROUP HOLD has a trailing twelve months EPS of kr-0.14.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -5.15%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, CRAYON GROUP HOLD’s stock is considered to be oversold (<=20).

Volatility

CRAYON GROUP HOLD’s last week, last month’s, and last quarter’s current intraday variation average was 1.52%, 0.22%, and 2.04%.

CRAYON GROUP HOLD’s highest amplitude of average volatility was 1.60% (last week), 1.53% (last month), and 2.04% (last quarter).

Moving Average

CRAYON GROUP HOLD’s worth is way higher than its 50-day moving average of kr105.78 and way higher than its 200-day moving average of kr98.16.

Yearly Top and Bottom Value

CRAYON GROUP HOLD’s stock is valued at kr117.10 at 22:40 EST, under its 52-week high of kr127.40 and way above its 52-week low of kr71.40.

More news about CRAYON GROUP HOLD.

7. WALLENIUS WILHELMS (WAWI.OL)

-9.97% Price Change

Wallenius Wilhelmsen ASA, together with its subsidiaries, engages in the logistics and transportation business worldwide. It operates through three segments: Shipping Services, Logistics Services, and Government Services. The company provides liner services through a fleet of modern and versatile RoRo vessels, which carry a mix of products, such as auto, construction, mining, agriculture machinery, and breakbulk products. In addition, it offers inland transportation services, as well as operates vehicle and equipment processing centers and inland distribution networks. The company serves agriculture, automotive, aviation, boats and yachts, breakbulk, commercial vehicles, construction, machinery and machine tools, mining, oil and gas, power and energy, and rail industries. It operates approximately 125 vessels servicing 15 trade routes, 66 processing centers, and 8 marine terminals. Wallenius Wilhelmsen ASA was founded in 1861 and is based in Lysaker, Norway.

Oslo Børs Benchmark Index_GI ended the session with WALLENIUS WILHELMS sliding 9.97% to €91.65 on Friday while Oslo Børs Benchmark Index_GI dropped 2.94% to €1,408.88.

Earnings Per Share

As for profitability, WALLENIUS WILHELMS has a trailing twelve months EPS of kr22.46.

PE Ratio

WALLENIUS WILHELMS has a trailing twelve months price to earnings ratio of 4.08. Meaning, the purchaser of the share is investing kr4.08 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 25.2%.

More news about WALLENIUS WILHELMS.

8. ASML HOLDING (ASML.AS)

-8.8% Price Change

ASML Holding N.V. develops, produces, markets, sells, and services advanced semiconductor equipment systems for chipmakers. It offers advanced semiconductor equipment systems, including lithography, metrology, and inspection systems. The company also provides extreme ultraviolet lithography systems; and deep ultraviolet lithography systems comprising immersion and dry lithography solutions to manufacture various range of semiconductor nodes and technologies. In addition, it offers metrology and inspection systems, including YieldStar optical metrology systems to assess the quality of patterns on the wafers; and HMI electron beam solutions to locate and analyze individual chip defects. Further, the company provides computational lithography solutions, and lithography systems and control software solutions; and refurbishes and upgrades lithography systems, as well as offers customer support and related services. It operates in Japan, South Korea, Singapore, Taiwan, China, rest of Asia, the Netherlands, rest of Europe, the Middle East, Africa, and the United States. The company was formerly known as ASM Lithography Holding N.V. and changed its name to ASML Holding N.V. in 2001. ASML Holding N.V. was founded in 1984 and is headquartered in Veldhoven, the Netherlands.

AEX-Index ended the session with ASML HOLDING falling 8.8% to €756.90 on Friday while AEX-Index dropped 3.11% to €878.91.

Earnings Per Share

As for profitability, ASML HOLDING has a trailing twelve months EPS of €17.1.

PE Ratio

ASML HOLDING has a trailing twelve months price to earnings ratio of 44.26. Meaning, the purchaser of the share is investing €44.26 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 48.57%.

More news about ASML HOLDING.

9. NORDIC SEMICONDUC (NOD.OL)

-8.57% Price Change

Nordic Semiconductor ASA, a fabless semiconductor company, designs, sells, and delivers integrated circuits (ICs) and related products and services for use in short- and long- range wireless applications in Europe, the Americas, and the Asia Pacific. The company offers cellular IoT solutions comprising NB-IoT and LTE-M; Wi-Fi solution; Bluetooth Low Energy Systems-on-Chip (SoCs); Bluetooth LE audio products; Bluetooth mesh; Bluetooth direction finding solution; DECT NR+, a non-cellular radio standard; Thread, an IP-based wireless networking protocol solution; Zigbee products; ANT solutions, including wireless multiprotocol SoCs supporting the ANT wireless protocol; nRF52 and nRF51 wireless SoCs; and range extenders. It also provides Matter, a Connected Home over IP solution; Amazon sidewalk; multiprotocol SoCs; Bluetooth wireless technology; security solution; power management ICs comprising nPM1100 PMIC, nPM1300 PMIC, and nPM6001 PMIC; cloud services, such as location, security, and device management services; nRF Cloud solution; and application specific integrated circuits and related consulting services. The company's products are used in various applications, such as audio, automotive, asset tracking, beacon, computer peripherals, connected health, smart agriculture, smart home and metering, education, building automation, LED lighting, logistics and transport, retail and payment, sports and fitness, toys and gaming, virtual reality and augmented reality products, and wearables. Nordic Semiconductor ASA was founded in 1983 and is headquartered in Trondheim, Norway.

Oslo Børs Benchmark Index_GI ended the session with NORDIC SEMICONDUC sliding 8.57% to €129.05 on Friday while Oslo Børs Benchmark Index_GI dropped 2.94% to €1,408.88.

Earnings Per Share

As for profitability, NORDIC SEMICONDUC has a trailing twelve months EPS of kr-1.2.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -3.62%.

Volume

Today’s last reported volume for NORDIC SEMICONDUC is 1176310 which is 140.27% above its average volume of 489565.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, NORDIC SEMICONDUC’s stock is considered to be oversold (<=20).

Revenue Growth

Year-on-year quarterly revenue growth declined by 48.8%, now sitting on 471.94M for the twelve trailing months.

More news about NORDIC SEMICONDUC.

10. ELLIPTIC LABORATOR (ELABS.OL)

-8.33% Price Change

Elliptic Laboratories ASA, an artificial intelligence (AI) software company, engages in the provision of AI virtual smart sensors for the smartphone, laptop, Internet of Things, and automotive industries in Norway, the United States, China, South Korea, Taiwan, and Japan. The company offers AI Virtual Human Presence Sensor, a presence-detection solution used to improve the security of data stored on devices and to allow intuitive responses based on natural human interaction; AI Virtual Proximity Sensor that enables exquisite full-screen devices; and AI Virtual Connection Sensor that allows to pair and authenticate smart devices in the same room. It also provides AI Virtual Position Sensor which automatically detects the location of an external display in relation to a laptop; AI Virtual Gesture Sensor, a touch-free ultrasound gesture technology, that enables touchless user interactions; AI Virtual Breathing sensor that enables to track person's breathing; and AI Virtual heart Sensor that tracks a person's heart rate. The company was incorporated in 2006 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with ELLIPTIC LABORATOR falling 8.33% to €11.66 on Friday while Oslo Børs Benchmark Index_GI dropped 2.94% to €1,408.88.

Earnings Per Share

As for profitability, ELLIPTIC LABORATOR has a trailing twelve months EPS of kr-0.24.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -7.11%.

More news about ELLIPTIC LABORATOR.

Stay up to date with our winners and losers daily report